Funding for this research was provided by:
Ontario Brain Institute (POND)
Text and Data Mining valid from 2019-08-19
Received: 11 October 2018
Accepted: 29 July 2019
First Online: 19 August 2019
Ethics approval and consent to participate
: The study was approved by the SickKids Research Ethics Board, and informed written consent and verbal assent were obtained from parents and children, respectively.
: All authors approve the publication of this manuscript.
: Russell Schachar provides consultation to Highland Therapeutics/Ironshore Pharmaceuticals, has stock in ehave biotechnology company and previously was a consultant to Lilly Corp and Purdue Pharma. Evdokia Anagnostou provides consultation to Roche, receives in-kind support from AMO Pharma and Clinical Research Associates, receives royalties from APPI, Springer and an honoraria from Wiley. Alexandra Mogadam, Anne E. Keller, Jason P. Lerch and Elizabeth W. Pang report no conflicts of interest.